{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:29:56Z","timestamp":1794684596449,"version":"4.9.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1169","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the diagnostic accuracy of 18F-FDG positron emission tomography (PET) or PET\/computed tomography (CT) in detecting histological transformation (HT) of indolent lymphomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic search of articles up to July 2024 was performed in Embase and Medline. Eligible studies included adults with histologically proven indolent lymphoma, 18F-FDG PET or PET\/CT as the index test, and sufficient data to assess diagnostic performance. Summary receiver operating characteristic curves were plotted using a bivariate model to estimate diagnostic accuracy with area under the curve (AUC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifteen studies with 1307 participants were included. Ten studies assessed PET ability to detect Richter\u2019s transformation, and 5 studies focused on HT in follicular lymphoma and other subtypes. A meta-analysis of the former showed pooled sensitivity of 0.90 (95% CI, 0.84-0.93) and specificity of 0.54 (95% CI, 0.28-0.77) when using a maximum standardized uptake value (SUVmax) threshold of around 5. AUC was 0.89. Pooled sensitivity was 0.74 (95% CI, 0.54-0.87), and specificity was 0.84 (95% CI, 0.67-0.93) when using an SUVmax threshold of around 10. Area under the curve was 0.84. For detecting HT in follicular lymphoma, thresholds were found higher than those for Richter\u2019s transformation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>18F-FDG PET or PET\/CT demonstrates good diagnostic accuracy to detect Richter\u2019s transformation, best when employing SUVmax \u2265 5. SUVmax thresholds may be limited in discriminating follicular lymphoma from HT, and alternatives should be sought.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge<\/jats:title>\n                  <jats:p>If biopsy is feasible, SUVmax \u2265 5 can guide biopsy in patients with clinically suspicious Richter\u2019s transformation. If biopsy is infeasible, SUVmax \u2265 10 can better identify HT and guide patient management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjr\/tqaf028","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:53:11Z","timestamp":1739299991000},"page":"669-678","source":"Crossref","is-referenced-by-count":8,"title":["18F-FDG PET or PET\/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-7157","authenticated-orcid":false,"given":"Osher N Y","family":"Lee","sequence":"first","affiliation":[{"name":"Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh , Edinburgh EH16 4SB,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University of Toronto , Toronto, ON M5G 2M9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network , Toronto, ON M5G 2M9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Veit-Haibach","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto; Department of Medical Imaging, University Health Network, Sinai Health Systems & Women\u2019s College Hospital, University of Toronto , Toronto, ON M5G 2M9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur","family":"Metser","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto; Department of Medical Imaging, University Health Network, Sinai Health Systems & Women\u2019s College Hospital, University of Toronto , Toronto, ON M5G 2M9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"2025042203521407000_tqaf028-B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of non-Hodgkin\u2019s lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"2025042203521407000_tqaf028-B2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1182\/asheducation-2005.1.314","article-title":"Biology and management of histologic transformation of indolent lymphoma","volume":"2005","author":"Freedman","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2025042203521407000_tqaf028-B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","article-title":"Transformed follicular lymphoma","volume":"97","author":"Fischer","year":"2018","journal-title":"Ann Hematol"},{"key":"2025042203521407000_tqaf028-B4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNM.0b013e328342b9d2","article-title":"Features of large cell transformation of indolent lymphomas as observed on sequential PET\/CT","volume":"32","author":"Karam","year":"2011","journal-title":"Nucl Med Commun"},{"key":"2025042203521407000_tqaf028-B5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/0971-3026.125626","article-title":"FDG-PET\/CT in lymphoma","volume":"23","author":"D'Souza","year":"2013","journal-title":"Indian J Radiol Imaging"},{"key":"2025042203521407000_tqaf028-B6","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma","volume":"23","author":"Sch\u00f6der","year":"2005","journal-title":"J Clin Oncol"},{"key":"2025042203521407000_tqaf028-B7","first-page":"7","article-title":"Value of 18F-FDG PET\/CT in discrimination between indolent and aggressive non-Hodgkin\u2019s lymphoma: a study of 328 patients","volume":"21","author":"Alobthani","year":"2018","journal-title":"Hell J Nucl Med"},{"key":"2025042203521407000_tqaf028-B8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","article-title":"The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)","volume":"20","author":"Noy","year":"2009","journal-title":"Ann Oncol"},{"key":"2025042203521407000_tqaf028-B9","first-page":"1267","article-title":"Detection of Richter\u2019s transformation of chronic lymphocytic leukemia by PET\/CT","volume":"47","author":"Bruzzi","year":"2006","journal-title":"J Nucl Med"},{"key":"2025042203521407000_tqaf028-B10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3109\/10428194.2015.1099643","article-title":"An 18F-FDG-PET maximum standardized uptake value &gt; 10 represents a novel valid marker for discerning Richter\u2019s syndrome","volume":"57","author":"Michallet","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"2025042203521407000_tqaf028-B11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","article-title":"High SUV uptake on FDG\u2013PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG\u2013PET\/CT staging in lymphoma","volume":"20","author":"Ngeow","year":"2009","journal-title":"Ann Oncol"},{"key":"2025042203521407000_tqaf028-B12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.clml.2023.07.008","article-title":"Clinical application of 18F-FDG-PET quantification in hematological malignancies: emphasizing multiple myeloma, lymphoma and chronic lymphocytic leukemia","volume":"23","author":"Zirakchian Zadeh","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025042203521407000_tqaf028-B13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"2025042203521407000_tqaf028-B14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13643-019-1188-0","article-title":"How should systematic reviewers handle conference abstracts? A view from the trenches","volume":"8","author":"Scherer","year":"2019","journal-title":"Syst Rev"},{"key":"2025042203521407000_tqaf028-B15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2025042203521407000_tqaf028-B16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","article-title":"Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach","volume":"59","author":"Chu","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2025042203521407000_tqaf028-B17","doi-asserted-by":"publisher","first-page":"e2019007","DOI":"10.4178\/epih.e2019007","article-title":"Diagnostic test accuracy: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"key":"2025042203521407000_tqaf028-B18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025042203521407000_tqaf028-B19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3324\/haematol.12013","article-title":"Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma","volume":"93","author":"Bodet-Milin","year":"2008","journal-title":"Haematologica"},{"key":"2025042203521407000_tqaf028-B20","first-page":"873","author":"Zheng","year":"2020"},{"key":"2025042203521407000_tqaf028-B21","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/j.clml.2020.12.003","article-title":"2-[18F]-FDG PET\/CT role in detecting Richter transformation of chronic lymphocytic leukemia and predicting overall survival","volume":"21","author":"Albano","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025042203521407000_tqaf028-B22","author":"Zhang","year":"2016"},{"key":"2025042203521407000_tqaf028-B23","author":"Du","year":"2015"},{"key":"2025042203521407000_tqaf028-B24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2967\/jnumed.114.149625","article-title":"18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma","volume":"56","author":"Wondergem","year":"2015","journal-title":"J Nucl Med"},{"key":"2025042203521407000_tqaf028-B25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/cam4.4924","article-title":"FDG-PET\/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma","volume":"12","author":"Rajam","year":"2023","journal-title":"Cancer Med"},{"key":"2025042203521407000_tqaf028-B26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1182\/bloodadvances.2023011566","article-title":"Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma","volume":"8","author":"Wai","year":"2024","journal-title":"Blood Adv"},{"key":"2025042203521407000_tqaf028-B27","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/cancers16091778","article-title":"The diagnostic performance of 2-[(18)F]FDG PET\/CT in identifying Richter transformation in chronic lymphocytic leukemia: an updated systematic review and bivariate meta-analysis","volume":"16","author":"Albano","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025042203521407000_tqaf028-B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jha2.615","article-title":"Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomas","volume":"4","author":"Obeid","year":"2023","journal-title":"eJHaem"},{"key":"2025042203521407000_tqaf028-B29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hon.2181","article-title":"Role of 18F-FDG-PET\/CT in the management of marginal zone B cell lymphoma","volume":"33","author":"Carrillo-Cruz","year":"2015","journal-title":"Hematol Oncol"},{"key":"2025042203521407000_tqaf028-B30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/cncr.22807","article-title":"The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma","volume":"110","author":"Tsukamoto","year":"2007","journal-title":"Cancer"},{"key":"2025042203521407000_tqaf028-B31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-021-02094-5","article-title":"Significance of initial, interim and end-of-therapy 18F-FDG PET\/CT for predicting transformation risk in follicular lymphoma","volume":"21","author":"Xie","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2025042203521407000_tqaf028-B32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/BLOOD.2019001091","article-title":"Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study","volume":"135","author":"Mir","year":"2020","journal-title":"Blood"},{"key":"2025042203521407000_tqaf028-B33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1080\/10428194.2020.1779254","article-title":"Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort","volume":"61","author":"Madsen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2025042203521407000_tqaf028-B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00277-017-3154-z","article-title":"Current prognostic and predictive factors in follicular lymphoma","volume":"97","author":"Sorigue","year":"2018","journal-title":"Ann Hematol"},{"key":"2025042203521407000_tqaf028-B35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1634\/theoncologist.2015-0036","article-title":"Imaging in lymphoma: the key role of fluorodeoxyglucose-positron emission tomography","volume":"20","author":"Meignan","year":"2015","journal-title":"Oncologist"},{"key":"2025042203521407000_tqaf028-B36","doi-asserted-by":"publisher","first-page":"943151","DOI":"10.3389\/fonc.2022.943151","article-title":"Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET\/CT","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"2025042203521407000_tqaf028-B37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/rlu.0000000000002879","article-title":"Prognostic value of baseline total metabolic tumor volume measured on FDG pet in patients with Richter syndrome","volume":"45","author":"Pontoizeau","year":"2020","journal-title":"Clin Nucl Med"},{"key":"2025042203521407000_tqaf028-B38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13643-019-1131-4","article-title":"An algorithm for the classification of study designs to assess diagnostic, prognostic and predictive test accuracy in systematic reviews","volume":"8","author":"Mathes","year":"2019","journal-title":"Syst Rev"},{"key":"2025042203521407000_tqaf028-B39","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2023"},{"key":"2025042203521407000_tqaf028-B40","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1182\/blood-2013-11-536169","article-title":"Correlation between FDG\/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia","volume":"123","author":"Falchi","year":"2014","journal-title":"Blood"},{"key":"2025042203521407000_tqaf028-B41","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.3324\/haematol.2018.207068","article-title":"Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy","volume":"104","author":"Mato","year":"2019","journal-title":"Haematologica"},{"key":"2025042203521407000_tqaf028-B42","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/leu.2015.21","article-title":"Diagnostic and prognostic role of PET\/CT in patients with chronic lymphocytic leukemia and progressive disease","volume":"29","author":"Mauro","year":"2015","journal-title":"Leukemia"},{"key":"2025042203521407000_tqaf028-B43","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3324\/HAEMATOL.2019.240564","article-title":"The role of 18F-FDG-PET in detecting Richter\u2019s transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqaf028\/61850687\/tqaf028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/98\/1169\/669\/61850687\/tqaf028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/98\/1169\/669\/61850687\/tqaf028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:52:26Z","timestamp":1745308346000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/98\/1169\/669\/8008996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":43,"journal-issue":{"issue":"1169","published-online":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqaf028","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,11]]}}}